• SENSEX 81,911.01
    31.61 (+0.04%)
  • BANKNIFTY 60,792.40
    1,051.15 (+1.76%)
  • NSE
    1,994.50 1,965.00(%)
  • Reliance Industries
    1,342.10 1,611.20(%)
  • ICICI Bank
    1,592.20 1,616.70(%)
  • Kalyan Jewellers
    716.00 689.00(%)
  • Cupid
    389.00 369.70(%)
  • HDFC Bank
    813.90 1,017.90(%)
  • Sai Life
    1,881.05 786.15(%)
  • SBI
    1,089.00 1,234.80(%)
  • Kotak Mah. Bank
    494.00 491.00(%)
  • Page Industries
    31,752.10 29,800.00(%)
  • M & M
    3,369.00 2,743.15(%)
  • Gabriel India
    1,690.25 1,600.00(%)
  • Bharti Airtel
    2,071.35 1,726.05(%)
  • Cummins India
    4,311.70 6,142.80(%)
  • N S D L
    815.00 1,180.00(%)
  • Hind.Aeronautics
    4,738.80 3,479.20(%)
  • Avanti Feeds
    798.20 1,592.30(%)
  • Indegene
    672.00 638.50(%)
  • Lenskart Solut.
    738.30 767.40(%)
  • Hindustan Copper
    467.35 759.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Orchid Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3135.0
  • ISIN : INE191A01027
866.70 -17 (-1.96%)
  • As on 12 Nov 2026 (EOD)

  • Today’s Low

    861.00

  • Today’s High

    901.95

  • Open

    901.95

  • Perv Close

    884.00

  • 52W Low

    480.00

  • 52W High

    1,143.50

Key Indicators

  • P/E(TTM)

    107.61

  • Mar.Cap (₹Cr.)

    5,190.25

  • Div & Yield %

    0.00

  • Book Value(₹)

    274.97

  • Debt-Equity Ratio

    -1.96

  • AGM Date

    11-Nov-2026

  • EPS

    8.07

  • P/E Ratio

    107.61

Financials Ratios

  • Debt-Equity Ratio

    0.25

  • Mar.Cap (₹Cr.)

    5,190.25

  • RONW (%)

    3.02

  • ROCE (%)

    3.20

Score Board

  • Equity (₹ in Cr.)

    59.89

  • BV (₹)

    275.00

  • Sales( ₹ in Cr.)

    1,232.78

  • NP (in Cr.)

    47.24

  • NP Var(%)

    -68.0

  • Div%

    0.0

  • CPS (₹)

    15.10

  • EPS (₹)

    7.90

  • Traded Value (₹ in Lakhs)

    5,200.73

  • 52 Week High

    1,143.50

  • 52 Week Low

    480.00

  • Price BSE

    868.0

  • Price NSE

    867.00

  • Market Capital( in Cr.)

    5,200.73

  • P/C Ratio

    57.40

  • P/E Ratio

    110.00

  • Price Vs.BV

    7.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,232.78 1,397.61 819.37 665.90 556.97 450.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,232.78 1,397.61 819.37 665.90 556.97 450.70
Other Income 56.49 36.43 30.39 58.64 56.97 6.46
Stock Adjustments -71.38 21.95 43.89 21.48 22.73 15.69
Total Income 1,217.89 1,455.99 893.65 746.02 636.67 472.85
EXPENDITURE :            
Raw Materials 773.08 915.30 528.35 406.10 336.80 244.96
Power and Fuel Cost 89.62 100.07 62.92 61.26 52.74 39.31
Employee Cost 114.32 109.23 69.64 65.35 60.21 64.40
Other Manufacturing Expenses 47.89 51.91 32.65 29.19 26.26 24.26
Selling and Administration Expenses 66.80 73.41 53.17 34.96 37.77 31.58
Miscellaneous Expenses 38.89 18.47 5.46 7.28 7.22 24.38
Employee Benefit Expenses 114.32 109.23 69.64 65.35 60.21 64.40
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,130.59 1,268.38 752.20 604.14 521.00 428.89
Operating Profit 87.30 187.61 141.45 141.88 115.67 43.96
Interest 9.32 13.25 16.71 32.90 33.46 52.21
Gross Profit 77.98 174.36 124.74 108.98 82.21 -8.25
Depreciation 43.36 41.91 33.22 54.79 87.02 108.90
Profit Before Tax 34.62 132.45 91.52 54.19 -4.81 -117.15
Current Tax 0.00 0.23 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 -9.69 -3.23 0.00 0.00 0.00
Reported Net Profit 34.62 141.90 94.75 54.19 -4.81 -117.15
Extraordinary Items -12.62 -5.89 -0.19 40.00 0.51 0.98
Adjusted Net Profit 47.24 147.79 94.94 14.19 -5.32 -118.13
Adjustment below Net Profit 0.00 238.80 0.00 0.00 0.00 0.00
P & L Balance brought forward -1,608.38 -1,988.38 -2,082.68 -2,136.64 -2,133.29 -2,016.74
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -1.18 0.70 0.45 0.23 -1.46 -0.60
P & L Balance carried down -1,572.58 -1,608.38 -1,988.38 -2,082.68 -2,136.64 -2,133.29
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 22.63 92.75 18.68 13.28 -1.18 -28.70
Earnings Per Share(Adj)-Unit Curr 22.63 92.75 18.68 13.28 -1.18 -28.70
Book Value 1,047.18 1,023.69 226.69 162.53 149.30 150.13
Book Value(Adj)-Unit Curr 1,047.18 1,023.69 226.69 162.53 149.30 150.13

Shareholding Pattern

  • Promoter Group

    74.45%

  • Public Share Holding

    25.55%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 19,254,312 32.15 19,254,312 21
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 25,331,740 42.30 25,331,740 2
Others 0 0.00 0 0
Sub Total 44,586,052 74.45 44,586,052 23
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 32,440 0.05 32,440 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 552,680 0.92 552,680 30
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 2,396 0.00 2,396 1
Insurance Companies 3,961 0.01 3,961 3
Mutual Funds / UTI 10,107,688 16.88 10,107,688 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 300,756 0.50 300,756 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,999,921 18.37 10,999,921 54
2] Non Institution
Bodies Corporate 803,466 1.34 800,228 407
Clearing Members 251 0.00 251 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 210,437 0.35 210,437 609
Foreign Non Institution Other 68 0.00 68 1
Hindu Undivided Families 136,411 0.23 136,411 982
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 457,675 0.76 457,675 15
Individuals holding nominal share capital up to Rs. 1 lakh 2,690,280 4.49 2,690,010 31,691
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4 0.00 4 1
Others 635 0.00 635 3
Sub Total 4,299,227 7.18 4,295,719 33,713
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 59,885,200 100.00 59,881,692 33,790

Company Background

Orchid Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Orchid Pharma Ltd
  • BSE Code : 3135.0
  • ISIN : INE191A01027

  • Incorporation Year

    1992

  • Registered Office

    Orchid Towers Nungambakkam
    313 Valluvar Kottam High Road, Chennai,
    Tamil Nadu-600034

  • Telephone

    91-44-28211000/28230000

  • FAX

    91-44-28211002

  • Chairman

    R G Agarwal

  • Managing Director

    Manish Dhanuka

  • Company Secretary

    Kapil Dayya

  • Auditor

    Singhi & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar


    ,
    ,
    Mumbai -

Orchid Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Orchid Pharma 868.45 1,289.27 1,232.78 126.78 1.68
Abbott India 26,100.20 7,217.19 6,929.05 33.56 43.78
Astrazeneca Phar 6,511.10 2,304.07 2,275.58 91.59 27.86
Glaxosmi. Pharma 2,726.40 3,932.76 3,790.20 40.51 58.17
Evonile Pharma 1,573.25 393.10 354.33 -1,380.04 15.94
Cipla 1,417.00 20,102.60 18,979.95 43.19 13.88
Bliss GVS Pharma 659.90 773.53 729.81 43.02 12.51
Amrutanjan Healt 517.45 520.13 502.55 26.11 24.16
Fermenta Biotec. 452.35 474.15 450.25 21.38 18.77
Guj. Themis Bio. 389.75 168.25 165.82 104.21 18.05
Ambalal Sarabhai 36.65 19.52 3.94 62.12 6.77